Next Article in Journal
Solvent Separating Secondary Metabolites Directly from Biosynthetic Tissue for Surface-Assisted Laser Desorption Ionisation Mass Spectrometry
Previous Article in Journal
Astaxanthin Protects Steroidogenesis from Hydrogen Peroxide-Induced Oxidative Stress in Mouse Leydig Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 13
Issue 3
10.3390/md13031389
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New Antimicrobial Bromotyrosine Analogues from the Sponge Pseudoceratina purpurea and Its Predator Tylodina corticalis

by
Michael P. Gotsbacher
and
Peter Karuso
*
Department of Chemistry & Biomolecular Sciences, Macquarie University, Sydney, NSW 2109, Australia
*
Author to whom correspondence should be addressed.
Mar. Drugs 2015, 13(3), 1389-1409; https://doi.org/10.3390/md13031389
Submission received: 9 January 2015 / Revised: 17 February 2015 / Accepted: 4 March 2015 / Published: 16 March 2015
Browse Figures
Versions Notes

Abstract

:
Bioassay-guided fractionation of extracts from temperate Australian collections of the marine sponge Pseudoceratina purpurea resulted in the isolation and characterisation of two new and six known bromotyrosine-derived alkaloids with antibiotic activity. Surprisingly, a single specimen of the mollusc Tylodina corticalis, which was collected while feeding on P. purpurea, contained only a few of the compounds found in the sponge suggesting selective accumulation and chemical modification of sponge metabolites.

1. Introduction

Sponges of the order Verongida are unique in the Demospongiae as the only group that contains alkaloids derived from bromotyrosine and sterols of the aplystane type; these are distinct chemotaxonomic markers for all the verongid genera [1,2,3]. The alkaloids have been reported to have antimicrobial [4,5,6,7], antifungal [8,9], cytotoxic [10,11,12,13,14,15,16,17,18,19,20,21], and antimalarial [22,23,24] activity for example and many have unique modes of action. Consequently, verongid sponges have no natural predators other than a few specialised molluscs such as nudibranchs [25].
In our continuing effort to isolate and identify new drug candidates from marine sponges [26] we screened temperate water sponges for antimicrobial and herbicidal activity. This revealed that the ethyl acetate partition of the ethanolic extract of Pseudoceratina purpurea (Carter 1880) displayed selective activity against Staphylococcus aureus (35 mm zone of inhibition in a disc diffusion assay with no activity against P. aeruginosa). This sponge has previously been reported to be a rich source of bromotyrosine-derived alkaloids with wide ranges of biological activity [8,12,16,27,28,29,30,31,32,33,34,35]. However, temperate Australian specimens of this sponge have not previously been investigated and it is a characteristic of this species that different alkaloid profiles have been found from sponges collected at different locations.
In addition we were also encouraged to investigate the natural products of this sponge because we observed, and collected, a single specimen of the opisthobranch Tylodina corticalis (Tate, 1889) feeding on this sponge. As Tylodina is a partially shelled mollusc it would be interesting to determine if this mollusc accumulates defensive chemicals from its diet, lending weight to the theory that chemical defence is a pre-adaptation to loss of the protective shell found in most molluscs [25,36]. Tylodina corticalis has not previously been chemically investigated, but Proksch et al. have published their work on Tylodina perversa from the Mediterranean [5,37,38,39]. In their study, they found that T. perversa, fed on a diet of Aplysina aerophoba sequestering uranidine, isofistularin-3, aerophobin 1, aerophobin 2, and aplysinamisin-1. Whereas aerophobin 2 and isofistularin-3 made up about one third of the total alkaloids each in the sponge, aerophobin 2 constituted ~70% of the alkaloids found in the mantles, mucus, and egg masses of T. perversa, indicating selective sequestration by the mollusc. Another 20% of the alkaloids found in T. perversa was attributed to aerothionin, which was not detected in the prey sponge suggesting that this compound may have come from a previous diet of a related sponge (e.g., A. cavernicola). Several species of Aplysina have been reported to contain high concentrations of aerothionin [13,40,41,42,43].
Herein we report the identification of 16 bromotyrosine alkaloids from Pseudoceratina purpurea and Tylodina corticalis by high resolution LC-MS/UV-Vis spectroscopy. Eight of these were isolated preparatively and subject to 2D NMR analysis, revealing two to be new compounds.

2. Results and Discussion

The ethanol extracts of both the sponge and mollusc appeared as yellow solutions, which quickly turned dark-purple when exposed to air. This suggested the presence of the well-known verongid sponge pigment uranidine [44]. As the crude extract showed selective activity against S. aureus (Supplementary Information), activity against this organism was used for the bioassay-guided isolation. The ethyl acetate partition of the ethanolic extract of P. purpurea was subject to gel filtration (Sephadex LH-20) and fractions (9–22), with activity against S. aureus, were combined. A similar extraction of T. corticalis yielded only 12 mg in the ethyl acetate partition so this was not subject to gel filtration but analysed without further fractionation. Comparison of the two extracts (Figure 1A,B) suggested a similar pattern of metabolites eluting around 20 min but the T. corticalis extract was much simpler in composition. However, more careful examination of this region (Figure 1C,D) showed that even the major peaks of the sponge and mollusc did not overlap exactly. Using nanospray HRMS in combination with UV-Vis spectra (Figure S1; Supplementary Information) allowed us to tentatively identify most of the compounds from both organisms (Table 1). While both organisms contained bromotyrosine-derived alkaloids, very little overlap in secondary metabolites between the two organisms existed (highlighted in grey in Table 1), which was surprising considering there was evidence of extensive feeding by T. corticalis on the sponge sample that was collected and extracted in this work.
Marinedrugs 13 01389 g001 1024
Figure 1. Low resolution-LCMS chromatograms (λmax 210 nm) of ethyl acetate partitions of P. purpurea (A) and T. corticalis (B); Panels (C) and (D) are expansions of the 19–21 min regions (λmax 280 nm).
Figure 1. Low resolution-LCMS chromatograms (λmax 210 nm) of ethyl acetate partitions of P. purpurea (A) and T. corticalis (B); Panels (C) and (D) are expansions of the 19–21 min regions (λmax 280 nm).
Marinedrugs 13 01389 g001
Table
Table 1. Low and high resolution LC-MS data from extracts of P. purpurea and T. corticalis.
Table 1. Low and high resolution LC-MS data from extracts of P. purpurea and T. corticalis.
RT (min) aλmax (nm)BrxbHR m/zMolecular Formula [M + H]+ΔppmP. purpureacT. corticaliscCompound c
13.7–14.2226, 2862489.9717, 491.9689, 493.9665C15H18Br2N5O4−0.306, −1.059, −1.413++++pseudoceratinin A (3)
14.67232, 2862494.0030, 496.0004, 497.9983C15H22Br2N5O4−0.306, −0.859, −0.913++purealidin L (10)
15.1–15.4228, 2852503.9878, 505.9848, 507.9824C16H20Br2N5O4+0.144, −0.809, −1.163+++++aerophobin 2 (4)
15.41234, 276, 3402680.9950, 682.9920, 684.9897C24H23Br2N6O8+0.937, +0.183, −0.070+ ceratinadin B (11)
16.35234, 276, 3372695.0095, 697.0067, 699.0046C25H25Br2N6O8−0.013, −0.767, −0.820++ new (ceratinadin D) (1)
18.48209, 2862489.9722, 491.9692, 493.9668C15H18N5O4Br2+0.194, −0.759, −1.113+ purealidin M (12)
19.00209, 2862503.9878, 505.9857, 507.9835C16H20Br2N5O4+ 0.144, +0.091, −0.063+ aerophobin 2 isomer
19.412100293.2335--+++C18 fatty acid methyl ester?
19.3–19.8223, 2804713.8461, 715.8431, 717.8400, 719.8376, 721.8355C21H24Br4N3O5+ 1.502, +0.749, −0.305, −0.658, −0.711++++hexadellin A (4)
19.85203, 2804741.8751, 743.8729, 745.8709, 747.8689, 749.8669C23H28Br4N3O5−0.598, −0.751, −0.705, −0.658, −0.611~+++purealidin P (13) or Q (14)
20.082100293.2333--~~C18 fatty acid methyl ester?
20.13203, 2804757.8720, 759.8688, 761.8660, 763.8634, 765.8616C23H28Br4N3O6+1.388, +0.234, −0.519, −1.073, −0.826 +++purealidin T (15) or purealidin P N-oxide (16)
20.30impure3633.9558, 635.9530, 637.9503, 639.9482C22H27Br3N3O4+1.179, +0.426, −0.227, −0.281+ aplysamine 7 (17), purpurealidin H (18), purpuramine I (19) or purpuramine L (20)
20.47–20.53222, 2803647.9707, 649.9673, 651.9644, 653.9627C23H29Br3N3O4+0.429, −0.924, −1.777, −1.431++++aplysamine 2 (6)
20.90234, 2793663.9649, 665.9630, 667.9609, 669.9587C23H29Br3N3O5−0.285, −0.139, −0.192, −0.345 ++purpuramine J (21 ) (aplysamine 2 N-oxide)
20.98210, 2783619.9397, 621.9368, 623.9340, 625.9320C21H25Br3N3O4+ 0.729, −0.124, −0.877, −0.831++ 16-debromo-aplysamine 4 (7)
21.71209, 2784697.8505, 699.8476, 701.8446, 703.8420, 705.8401C21H24Br4N3O4+1.017, +0.163, −0.790, −1.343, −1.197++ new (aplysamine 8) (2)
22.25209, 2784879.8942, 881.8915, 883.8894, 885.8871, 887.8850C27H30Br4N7O7+ 0.727, +0.073, +0.020, −0.233, −0.287++ purealine (8)
24.27240, 308, 3632404.9809, 406.9787, 408.9765C14H19Br2N2O2+ 0.120, −0.033, −0.186 +new unknown
a Retention times from LR LCMS trace (Figure 1); b number of bromine atoms from LR-MS molecular ion isotopic pattern; c +++; major metabolite, ++; medium abundance metabolite, +; minor metabolite; - no molecular formula was found and ~; trace metabolite; d tentative assignment based on HR-MS and UV (see Figure 2 and Figure 7); Grey indicates similarities between P. purpurea and T. corticalis. Italic indicates low accuracy for UV spectrum due to low sample concentration. Bold indicates new compounds.
Preparative HPLC separation of the eight major compounds from the sponge confirmed the tentative structures assigned by HR LC-MS and UV-Vis and that two of the compounds (1 and 2) were new (Figure 2). The six known compounds were (−)-pseudoceratinine A (3) [45]; (+)-aerophobin 2 (4) [46]; (−)-hexadellin A (5) [47]; aplysamine 2 (6) [48]; 16-debromoaplysamine 4 (7) [49]; (−)-purealin (8) [50] (Figure 2) and their NMR spectral data matched those reported in the literature. The two new compounds were subject to full spectral analysis to determine their structure and stereochemistry.
Ceratinadin D (1) was obtained as an optically active solid ( [ α ] D 20 +52) with UV maxima at 234, 276, and 337 nm, suggesting the presence of a spiro-cyclohexadienyl-isoxazoline (λmax 234, 276 nm) and a uranidine moiety (λmax 337 nm). The IR absorptions indicated the existence of OH and/or NH (3420, 3380, and 3290 cm−1) and an amide (1677 cm−1). The low resolution mass spectrum displayed an isotopic cluster (694.95, 696.95, 699.00 amu in ratio 1:2:1) suggesting two bromines were present. High resolution mass spectrometry suggested a molecular formula C25H2479Br2N6O8 (0.013 ppm error). These data matched reasonably well with those reported for (+)-ceratinadins A and B [9].
Marinedrugs 13 01389 g002 1024
Figure 2. Bromotyrosine-alkaloids isolated from the marine sponge P. purpurea.
Figure 2. Bromotyrosine-alkaloids isolated from the marine sponge P. purpurea.
Marinedrugs 13 01389 g002
The 13C NMR spectrum indicated the presence of 25 carbons (Table 2), one O-methyl (δ 59.7), four methylenes (δ 39.0, 38.2, 28.1, 21.6), three sp2 methines (δ 131.2, 124.2, 113.7), one sp3 methine (δ 73.5), 13 sp2 quaternaries (δ 154.5, 149.6, 147.6, 146.6, 139.9, 137.4, 128.9, 122.4,120.9, 117.8, 113.1, 112.6, 103.2), one sp3 quaternary (δ 90.1) and two carbonyls (δ 173.2, 158.9).
Table
Table 2. NMR (DMSO-d6, 600 MHz) data for new bromotyrosine compound (1).
Table 2. NMR (DMSO-d6, 600 MHz) data for new bromotyrosine compound (1).
PositionδCTypeδH, m (J in Hz)COSY (H no.)1H-13C HMBC (C no.)
173.5CH3.90 d (7.7)93, 4, 5, 6
2120.9C-
3147.6C-
4113.1C-
5131.2CH6.54 s12, 3, 4, 6 (w) a, 10
690.1C-
859.7CH33.63 s 3
9-OH6.36 d (7.7)11 (w), 4 (w), 6 (w)
1039.0CH23.59 d (3.6), 3.15 d (3.6)101, 5, 6, 11
11154.5C-
14158.9C-
16-NH8.51 t (5.8)1714
1738.2CH23.13 m1818, 19
1828.1CH21.73 m17, 1917, 19
1921.6CH22.51 m1818 (w), 20, 24
20122.4C-
21-NH11.93 bs2320 (w)
22146.6C-
23-NH12.15 bs21-
24117.8C-
25-NH27.28 bs
1′-NH11.76 d (6.4)2′3′, 5′
2′124.2CH7.64 d (6.4)1′4′, 10′
3′139.9C-
4′173.2C-
5′112.6C-
6′149.6C-
7′103.2C-
8′113.7CH6.83 s 24, 6′, 9′, 10′
9′137.4C-
10′128.9C-
11′-OH8.93 bs
12′-OH14.3 bs 5′, 6′ (w)
13′-OH10.25 bs 10′
a (w) denotes a weak correlation.
Use of one and two-dimensional NMR data (Table 2) enabled the construction of four substructures (Figure 3). Inspection of 1H, 13C, and 1H-1H COSY NMR spectra suggested that the following proton signals belonged to the same spin system: δH 6.54 (sp2 methine), δH 3.90 (sp3 methine), δH 3.63 (OMe), and an AB system (δH 3.59 and δH 3.15 each 1H) characteristic of a spirocycloisoxazoline ring previously published from other verongid compounds [51]. HMBC correlations from H-5 to C-1, C-2, C-3, H-8 to C-3, and H-10a/b to C-1, C-6, C-11 confirmed the 1-hydroxy-2,4-dibromo-3-methoxy-11-carbonyl spirocyclohexadienyl isoxazole (substructure A) and the connection between substructures A and B was obtained by an HMBC correlation from H-10a/b to C-14.
The signal at δH 8.51 (NH) showed a coupling to δH 3.13 (H-17) and an HMBC correlation to the amide carbonyl (C-14; δ 158.9). Further COSY correlations from H-17 to H-18 (δH 1.73), and in turn H-19 (δH 2.51) supported the conclusion that substructure B was an amide unit connected to a propyl chain (c.f. an ethyl chain in ceratinadin A and B).
Marinedrugs 13 01389 g003 1024
Figure 3. Structure and selected COSY (black) and HMBC (red) correlations of new bromotyrosine compound 1.
Figure 3. Structure and selected COSY (black) and HMBC (red) correlations of new bromotyrosine compound 1.
Marinedrugs 13 01389 g003
HMBC correlations between H-19 and C-20 and C-24 (Figure 4) indicated that the CH2 at δC 21.2 ppm was connected to the imidazole ring. The w-COSY correlation between two broad singlets at δH 11.93 (N-21H) and δH 12.15 (N-23H), and the 2H singlet at δH 7.77 suggested the imidazole is present in the form of an imidazolium salt. The presence of a homohistamine unit is commonly observed in verongid metabolites [51] and was also found in other metabolites from this sponge. For example, aerophobin, pseudoceratinin A, and purealin show similar NMR data for this substructure and provided good evidence for unit B/C. Although there were no correlations to C-22, a quaternary carbon at δ 146.6 was observed, which matches literature values for 2-aminoimidazole. Because of resonance and long T1 relaxation times, it is common not to observe correlations with guanidine carbons.
The HMBC correlations in the trihydroxy quinolinone (uranidine) ring system (H-1′ to C-2′ and C-10′) matched those previously reported for 7-substituted 3,6,9-trihydroxy quinolinone [52]. In addition, H-8′ also showed a correlation to C-10′ (see Figure 4b), which could only be observed with 7-substitution (c.f. from H7′ a 4JCH coupling would not be observable). If the uranidine moiety was attached at C-8′; 3JCH couplings should be observed from H-7′ to C-9′ and C-5′. The site of attachment at the imidazole was clearly indicated by strong correlations between C-24 and H-19 and H-8′ (Figure 4). Further evidence for the presence of unit D arose from 1H-1H coupling between H-2′ (δH 7.64, d, J = 5.8 Hz) and H-1′ (δH 11.76, d, J = 5.8 Hz).
Marinedrugs 13 01389 g004 1024
Figure 4. Selected HMBC correlations of 1: (a) from H-19 (δ 2.51) to C-20 (δ 122.4) and C-24 (δ 117.8) of the imidazole moiety. H-19 lies under the large DMSO peak (2.49 ppm). (b) from H-8′ (δ 6.83) 3J couplings to C-24 (δ 117.8) of the imidazole moiety, and to C-6′ (δ 149.6), C-10′ (δ 128.9) and a 2J coupling to C-9′ (δ 137.4) of the uranidine moiety.
Figure 4. Selected HMBC correlations of 1: (a) from H-19 (δ 2.51) to C-20 (δ 122.4) and C-24 (δ 117.8) of the imidazole moiety. H-19 lies under the large DMSO peak (2.49 ppm). (b) from H-8′ (δ 6.83) 3J couplings to C-24 (δ 117.8) of the imidazole moiety, and to C-6′ (δ 149.6), C-10′ (δ 128.9) and a 2J coupling to C-9′ (δ 137.4) of the uranidine moiety.
Marinedrugs 13 01389 g004
The chemical shifts for subunits A, C and D all aligned very well with those described for ceratinadin B [9], a compound similar to the one described here. However, ceratinadin B contains a histamine unit instead of homohistamine (subunit B) and thus a lower molecular weight. Due to the similarity of these two compounds, and with the other ceratinadins, we named this compound ceratinadin D. Finally, the specific rotation of 1 is very similar to that of ceratinadin B strongly suggesting the same absolute stereochemistry (1R, 6S).
Aplysamine 8 (2) was a simple bromotyrosine derivative (λmax 278 nm) with four bromines (M + H pentet; m/z 698 (1), 700 (4), 702 (6), 704 (4), 706 (1)). The HRMS was consistent with a molecular formula C21H23Br4N3O4 (Table 1). In addition, three characteristic bands in the infrared spectrum (νmax 3572, 1672 and 1001 cm−1), confirmed the presence of an oxime.
These data suggested the compound was aplysamine 4 (9) [10]. However, comparison of the 1H-NMR spectrum reported for aplysamine 4 differed to our compound (Table 3) in the following ways: In aplysamine 4, the aromatic protons from ring A and B are all at δH ~7.44. We found two different environments for the aromatic ring protons, where H-2 were at δH 7.44 but H-20 were at 7.55. This could be attributed to the use of different solvents but what was also different was the chemical shift of the ethyl and propyl-chain carbons. In aplysamine 4 the propyl group terminated with an ammonium ion (C-20 = 39.0 ppm) whereas in our compound, this carbon was at 36.2 ppm. Similarly the carbon shifts for the ethyl group did not match those of aplysamine 4.
Table
Table 3. NMR (DMSO-d6, 600 MHz) data for new bromotyrosine aplysamine 8 (2).
Table 3. NMR (DMSO-d6, 600 MHz) data for new bromotyrosine aplysamine 8 (2).
PositionδCTypeδH, m ( J in Hz)COSY (H no.)1H-13C HMBC (C no.)ROESY (H no.)
1136.3C-
2132.9CH7.44 s73, 47
3117.1C-
4151.8C-
660.4CH33.75 s 4
727.9CH23.76 s21, 2, 8, 112
8151.0C-
10-OH12.02 s 8 (w) a
11163.0C-
13-NH8.12 t (6.0)14147, 14, 16, 15 (w)
1436.2CH23.38 m13, 1511, 15, 1615, 16
1529.6CH21.96 m14, 1614, 1613 (w), 14, 16
1671.3CH23.88 t (6.4)1514, 1514, 15
18151.3C-
19117.6C-
20133.2CH7.55 s 18, 19, 2222, 23
21136.8C-
2231.5CH22.81 t (7.4) 20, 21, 2320, 23
2339.4CH23.05 m22, 2421(w)20, 22, 24
24-NH37.81 bs23-23
a (w) denotes a weak correlation.
The 13C NMR spectrum of our compound indicated the presence of 21 carbons, one O-methyl (δ 60.4), six methylenes (δ 71.3, 39.4, 36.2, 31.5, 29.6, 27.9), four sp2 methines (δ 133.2 × 2, 132.9 × 2), nine sp2 quaternary (δ 151.8, 151.3, 151.0, 136.8, 136.3, 117.6 × 2, 117.1 × 2) and one amide carbonyl (δ 163.0). All protonated carbons were assigned by HSQC experiment. Use of one and two-dimensional NMR data (Table 3) enabled the construction of three substructures (Figure 5). Inspection of 1H, 13C, and 1H-1H COSY NMR spectra suggested that the following proton signals belonged to substructure A: δH 12.02 (oxime), 7.44 (sp2 methine), 3.76 (sp3 methine) and 3.75 (OMe). HMBC correlations from H-2 to C-2, C-3, H-6 to C-4, and H-7a/b to C-8 and C-11 provided good evidence for the oxime-tyrosine unit A. The connection between substructures A and B was obtained by HMBC correlations from H-7a/b to carbonyl C-11 and from the amide proton H-13 to oxime carbon C-8. C-8 and C-11 could be easily distinguished by their typical chemical shifts as reported in the literature [51]. The geometry of the oxime was determined as E from the up-field 13C chemical shift of C-7 (δC 27.9), c.f. δC 35.7 for Z-oximes as observed in (E, Z)-N,N′-bis-[3-(3′-bromo-4′-hydroxyphenyl)-2-oximidopropionyl] cystamine [4].
The amide proton (δH 8.12) showed coupling to a methylene (δH 3.38) assigned to H-14. Further COSY correlations to δH 1.96, and then to δH 3.88 supported the assumption that substructure B was an amide unit connected to a propyl chain, attached to an oxygen (H-16 3.88 ppm; C-16 71.3 ppm from HSQC), which could only be explained by attachment to unit C via an ether linkage. Indeed, a weak correlation between C-18 (151.3 ppm) and H-16 was observed in the HMBC spectrum (Figure 6) and provided strong evidence for the assigned structure.
Marinedrugs 13 01389 g005 1024
Figure 5. Structure and selected 2D-NMR correlations of new bromotyrosine compound (2). (Colours: red (HMBC), green (ROESY), black (COSY)).
Figure 5. Structure and selected 2D-NMR correlations of new bromotyrosine compound (2). (Colours: red (HMBC), green (ROESY), black (COSY)).
Marinedrugs 13 01389 g005
Marinedrugs 13 01389 g006 1024
Figure 6. Selected HMBC correlations found in the unknown bromotyrosine (2; DMSO-d6, 600 MHz). A weak correlation between H-16 (δ 3.88) and C-18 (δ 151.3) indicates the link of substructures B and C.
Figure 6. Selected HMBC correlations found in the unknown bromotyrosine (2; DMSO-d6, 600 MHz). A weak correlation between H-16 (δ 3.88) and C-18 (δ 151.3) indicates the link of substructures B and C.
Marinedrugs 13 01389 g006
The signal at δH 7.55 (H-20) showed HMBC correlations to sp2 quaternary carbons (C-18, C-19) and a ROESY correlation to a methylene at δH 2.81/δC 31.5, consistent with attachment of an alkyl group directly to the aromatic ring, in support of substructure C. Direct coupling of δH 2.81 to δH 3.05, and of δH 3.05 to the primary amine protons at δH 7.80 were in good accordance to literature values [51] for a tyramine unit. Aplysamine 8 is thus an isomer of aplysamine 4 and considering the similarity in structure to aplysamines 1–7, no new name is required for this compound.
Putting the pieces together, we conclude that this is a new brominated tyrosine derivative (2) and, due to the similarities with previously described aplysamines 1–7, shall be named aplysamine 8.
Compounds 1–8 were bioassayed against E. coli and S. aureus (MTT microdilution assay; Supplementary Information). Only aplysamine 8 (2) was found to have any notable activity (MIC 125 μg/mL against E. coli and 31 μg/mL against S. aureus) c.f. ampicillin 1.1 μg/mL against S. aureus. Hexadellin (6), aplysamine 2 (7) and 16-debromoaplysamine 4 (8) had mild activity against S. aureus (125–250 μg/mL). While the MTT and disc diffusion assays are not directly comparable, the high antibacterial activity observed for the crude extract was not reflected in the bioassay of individual metabolites. This may be due to a cumulative effect of many weak antibiotics, synergistic or contingent effects as has previously been noted for other natural products [53].
Although opisthobranchs of the genus Tylodina are found in distant regions, they are exclusively associated with sponges of the order Verongida (in particular the family Aplysinellidae) [39]. Tylodina corticalis typically feed on the genus Pseudoceratina [54]. It has also been shown, that Tylodina spp accumulate the secondary metabolites (bromotyrosine alkaloids) from their prey, sequestered and utilised as feeding deterrents for themselves and their eggs [38,39,55,56].
Returning to the apparent lack of similarity between the metabolites positively identified from the sponge and those tentatively identified from T. corticalis, firstly it should be noted that the major difference is that many compounds found at high concentrations in the sponge were not found in the mollusc. This is, however, typically what is observed with other spongiverous molluscs such as nudibranchs, for example [25]. Next, four of the eight major compounds from the sponge were detected in the mollusc, albeit at a lower level and two of the minor/trace metabolites from the sponge were also detected in the mollusc at much higher relative concentrations. The notable difference is the high concentrations of purealidin T and purpuramine J, which were not observed in the sponge extract at all despite a careful search. However, purealidin T is the N-oxide of purealidin Q and purpuramine J is the N-oxide of aplysamine 2, a major alkaloid from the sponge. Taken together these observations suggest that the sponge metabolites are certainly accumulated on a selective basis (purealidin P/Q) but also that the mollusc might be modifying the sponge metabolites (purealidin T, purpuramine J) to N-oxides. Many cases of modification of sponge metabolites by predatory molluscs have previously been reported [57]. Certainly, the major metabolites isolated from T. corticalis are N-oxides closely related to compounds found in the sponge (Figure 7).
Marinedrugs 13 01389 g007 1024
Figure 7. Bromotyrosine derivatives tentatively identified from the ethyl acetate extracts of P. purpurea and T. corticalis based on UV and HR-MS analysis. The boxed structures are possible isomeric forms present. Stereochemistry shown as reported in the literature.
Figure 7. Bromotyrosine derivatives tentatively identified from the ethyl acetate extracts of P. purpurea and T. corticalis based on UV and HR-MS analysis. The boxed structures are possible isomeric forms present. Stereochemistry shown as reported in the literature.
Marinedrugs 13 01389 g007

3. Experimental Section

3.1. General Experimental Procedures

1H NMR and 13C NMR spectra were recorded in 5 mm Pyrex tubes on a Bruker Avance DPX-400 400 MHz or DRX-600K 600 MHz spectrometer. All spectra were obtained at 25 °C, processed using Bruker Topspin 1.3 and referenced to residual solvent (DMSO-d6 2.50/39.52 ppm). Infrared spectra were taken on a Perkin Elmer paragon 1000PC FTIR spectrometer, or Nicolet iS10 FT-IR Spectrometer (Thermo Scientific, Scorsby, Australia). UV measurements were performed on a NanoDrop 2000 UV-Vis-Spectrophotometer (Thermo Scientific, Scorsby, Australia). The specific optical rotation was measured on a Jasco P-1010 Polarimeter (Jasco, Tokyo, Japan). Low resolution mass spectrometry was performed by electrospray ionisation (ESI) MS in positive polarity mode on a Shimadzu LC-20A prominence system coupled to a LCMS-2010 EV mass spectrometer using LCMSsolution 3.21 software. LC-MS experiments were carried out on a Gemini C18 column (Phenomenex, Sydney, Australia) 150 × 2 mm, 110Å, 3 µm. High resolution-LC-MS experiments were carried out on a Thermo Orbitrap Elite mass spectrometer with Easy Spray source. The samples were loaded on a C18 trap column (Acclaim, Pepmap 100, 75 µm × 2 cm, nanoviper, C18, 3 µm, 100 Å) and switched online to the analytical column (Thermo, Easy Spray column, PepMap C18 column RSLC, C18, 2 µm, 100 Å, 50 µm × 15 cm) after desalting. Samples were analysed in positive polarity mode using XCalibur2.2 software.
HPLC separations were achieved on a Shimadzu 10AD-VP system running Class-VP 7.4 SP1 software. Analytical and preparative HPLC were performed on Gemini C18 HPLC columns (Phenomenex, Sydney, Australia): Gemini-NX C18 250 × 4.6 mm, 110Å, 5 µm and Gemini-NX C18 150 × 21.2 mm, 110Å, 5 µm respectively. TLC was performed with Merck Kieselgel 60 F254 plates with viewing under ultraviolet light (254 nm and 365 nm) and/or by heating, after treatment with 10% phosphomolybdic acid in ethanol. Flash column chromatography was performed on silica gel (60 Å 0.040–0.063 mm, 230–400 mesh ASTM from Merck).

3.2. Animal Material

The sponge (654 g) was collected by hand at Jervis Bay, NSW, Australia (S 35°08′07″, E 150°43′33″, at 1–4 m depth) under New South Wales Department of Primary Industries collecting permitNo. P08/0006-1.1. The samples were frozen upon collection and stored at −20 °C. It was identified as Pseudoceratina purpurea Carter (phylum Porifera, class Demospongiae, order Verongida, family Aplysinellidae). A voucher specimen (JB-S07) was prepared according to Hooper [58] and deposited at the Department of Chemistry and Biomolecular Sciences, Macquarie University. The opisthobranch Tylodina corticalis (Tate) was found feeding on the sponge Pseudoceratina purpurea. One individual was separated from the sponge, frozen at −20 °C in the field and stored at −80 °C in the laboratory.

3.3. Bioassays

Detailed descriptions of the bioassay-guided fractionation, as well as protocols for the disc diffusion and MTT assay can be found in the Supplementary Information.

3.4. Extraction and Isolation

The frozen sponge (654 g) was homogenised in distilled ethanol (4 × 1000 mL) and the combined ethanol extracts filtered through celite and evaporated to approximately 1000 mL. An aliquot (20 mL) was, freeze dried and stored at −80 °C. The remaining solution was partitioned against petroleum ether (3 × 500 mL), ethyl acetate (5 × 500 mL), and 1-butanol (3 × 200 mL) to yield 0.9076 g, 6.5420 g, and 0.2241 g of crude extracts respectively. The crude ethyl acetate extract (3.5 g) was subjected to gel permeation chromatography (Sephadex LH-20; 1:1 chloroform:methanol) and fractions 9–22, containing all the natural products were combined. The resulting dark residue (1.66 g) was purified by HPLC (preparative C18 column, 9.99 mL/min, gradient from 18% to 40% acetonitrile:water:0.05% TFA over 40 min).
(+)-Ceratinadin D (1): Unstable brown amorphous solid (4.5 mg; 0.011% of wet weight). [ α ] D 20 +52° (c 0.45, MeOH). λmax (MeOH) 234, 276, 337 nm. νmax (neat film) 3420 (m), 3380 (m), 3290 (m), 1677 (s), 1432 (s), 1202 (d), 1135 (s), 1047 (s), 1025 (br), 802 (s), 764 (s), 722 (s) cm−1. 1H-NMR (600 MHz, DMSO-d6) δ 14.3 (bs, H-12′), 12.15 (bs, H-23), 11.93 (bs, H-21), 11.76 (d, J = 6.4 Hz, H-1′), 10.25 (bs, H-13′), 8.93 (bs, H-11′), 8.51 (t, J = 5.8 Hz, H-16), 7.28 (bs, (H-25)2), 7.64 (d, J = 6.4 Hz, H-2′), 6.83 (s, H-8′), 6.54 (s, H-5), 6.36 (d, J = 7.9 Hz, H-9), 3.90 (d, J = 7.6 Hz, H-1), 3.63 (s, OMe), 3.59 (d, J = 3.6 Hz, H-10a), 3.15 (d, J = 3.6 Hz, H-10b), 3.13 (m, (H-17)2), 2.51 (s, (H-19)2), 1.73 (m, (H-18)2). 13C-NMR (150 MHz, DMSO-d6) δ 173.2 (C-4′), 158.9 (C-14), 154.5 (C-11), 149.6 (C-6′), 147.2 (C-3), 146.6 (C-22), 139.9 (C-3′), 137.4 (C-9′), 131.2 (C-5), 128.9 (C-10′), 124.2 (C-2′), 122.4 (C-20), 120.9 (C-2), 117.8 (C-24), 113.7 (C-8′), 113.1 (C-4), 112.6 (C-5′), 103.7 (c-7’), 90.1 (C-6), 73.6 (C-1), 59.7 (C-8), 39.0 (C-10), 38.2 (C-17), 28.1 (C-18), 21.6 (C-19). Mass spectrum (ESI+) m/z: isotopic cluster 695:697:699 (in ratio 1:2:1). (HRESI+) Found m/z: 695.0067, C25H25N6O879Br2 requires 695.0101.
Aplysamine 8 (2): Light yellow solid (0.9 mg; 0.002% of wet weight). λmax (MeOH) 209, 278 nm. νmax (neat film) 3572 (m), 3187 (m), 3061 (m), 2930 (m), 1721 (m), 1685 (s) 1672 (m), 1642 (m), 1631 (m), 1546 (m), 1422 (s), 1258 (s), 1201 (br), 1001 (s), 835 (s), 734 (s), 721 (s) cm−1. 1H-NMR (400 MHz, DMSO-d6) δ 12.02 (s, H-10), 8.12 (t, J = 6.0 Hz, H-13), 7.81 (bs, (H-24)2), 7.55 (s, (H-20)2), 7.44 (s, (H-2)2), 3.88 (t, J = 6.4 Hz, (H-16)2), 3.76 (s, (H-7)2), 3.75 (s, OMe), 3.38 (m, (H-14)2), 3.05 (m, (H-23)2), 2.81 (t, J = 7.4 Hz, (H-22)2), 1.96 (m, (H-15)2). 13C-NMR (100 MHz, DMSO-d6) δ 163.0 (C-11), 151.8 (C-4), 151.3 (C-18), 151.0 (C-8), 136.8 (C-21), 136.3 (C-1), 133.2 ((C-20)2), 132.9 ((C-2)2), 117.6 ((C-19)2), 117.1 ((C-3)2), 71.3 (C-16), 60.4 (OMe), 27.9 (C-7), 39.4 (C-23), 36.2 (C-14), 31.5 (C-22), 29.6 (C-15). Mass spectrum (ESI+) m/z: isotopic cluster 698:700:702:704:706 (in ratio 1:4:6:4:1). (HRESI+) Found 697.8527, C21H2479Br4N3O4 requires 697.8500.
(−)-Pseudoceratinin A (3): [45] Unstable light yellow solid (15.4 mg; 0.038% of wet weight). [ α ] D 20 −154° (c 0.5, MeOH) Lit. −158°. 1H-NMR (600 MHz, DMSO-d6) δ 12.10 (s, NH-13), 11.80 (s, NH-12), 8.60 (t, J = 8.6 Hz, NH-9), 7.40 (NH2-14), 6.59 (s, H-13), 6.55 (bs, C1-OH), 6.54 (s, H-5), 3.89 (s, H-1), 3.62 (s, OMe), 3.59 (d, J = 18.2 Hz, H-7a), 3.35 (q, J = 6.4 Hz, (H-10)2), 3.17 (d, J = 18.1 Hz, H-7b), 2.59 (t, J = 6.5 Hz, (H-11)2). 13C-NMR (150 MHz, DMSO-d6) δ 159.5 (C-9), 154.9 (C-8), 147.6 (C-3), 147.5 (C-14), 131.7 (C-5), 124.7 (C-12), 121.3 (C-2), 113.6 (C-4), 109.9 (C-13), 90.7 (C-6), 74.1 (C-1), 60.1 (MeO), 39.5 (C-7), 37.8 (C-10), 24.8 (C-11). Mass spectrum (ESI+) m/z: isotopic cluster 490:492:494 (in ratio 1:2:1).
(+)-Aerophobin 2 (4): [46] Off-white solid (9.1 mg; 0.022% of wet weight). [ α ] D 20 +128° (c 0.55, MeOH), Lit. [46] +139°. 1H-NMR (600 MHz, DMSO-d6) δ 12.11 (s, NH-14), 11.70 (s, NH-13), 8.57 (t, J = 5.9 Hz, NH-9), 7.37 (s, NH2-15), 6.57 (s, H-14), 6.56 (s, H-5), 3.90 (s, H-1), 3.63 (s, OMe), 3.60 (d, J = 17.8 Hz, H-7a), 3.18 (d, J = 17.8 Hz, H-7b), 3.16 (q, J = 6.6 Hz, (H-10)2), 2.39 (t, J = 7.4 Hz, (H-12)2), 1.69 (m, (H-11)2). 13C-NMR (150 MHz, DMSO-d6) δ 159.5 (C-9), 155.0 (C-8), 147.6 (C-3), 147.3 (C-15), 131.7 (C-5), 126.8 (C-13), 121.3 (C-2), 113.6 (C-4), 109.3 (C-14), 90.7 (C-6), 74.1 (C-1), 60.1 (MeO), 39.8 (C-7), 38.5 (C-10), 27.8 (C-11), 22.0 (C-12). Mass spectrum (ESI+) m/z: isotopic cluster 504:506:508 (in ratio 1:2:1).
(−)-Hexadellin A (5): [47] Slight-pink solid (8.1 mg; 0.020% of wet weight). [ α ] D 20 −19° (c 0.5, MeOH). 1H-NMR (400 MHz, DMSO-d6) δ 8.55 (t, J = 5.6 Hz, H-10), 7.82 (bs, (H-20)2), 7.57 (bs, (H-16)2), 6.56 (bs, H-5), 6.36 (bs, C1-OH), 3.94 (t, J = 6.2 Hz, (H-13)2), 3.90 (s, H-1), 3.62 (s, OMe), 3.58 (d, J = 18.2 Hz, H-7a), 3.19 (d, J = 18.2 Hz, H-7b), 3.38 (m, H-11), 3.05 (m, (H-19)2), 2.81 (t, J = 7.2 Hz, (H-18)2), 1.98 (m, (H-12)2). 13C-NMR (100 MHz, DMSO-d6) δ 159.4 (C-9), 155.0 (C-8), 151.7 (C-14), 147.6 (C-3), 137.3 (C-17), 133.7 (C-16), 131.7 (C-5), 121.3 (C-2), 118.1 (C-15), 113.6 (C-4), 90.7 (C-6), 74.1 (C-1), 71.7 (C-13), 60.1 (OMe), 39.0 (C-7), 39.0 (C-19), 36.7 (C-11), 32.0 (C-18), 29.9 (C-12). Mass spectrum (ESI+) m/z: isotopic cluster 714:716:718:720:722 (in ratio 1:4:6:4:1).
Aplysamine 2 (6): [48] Light brown solid (9.0 mg; 0.022% of wet weight). 1H-NMR (400 MHz, DMSO-d6) δ 11.90 (s, N-OH), 8.05 (t, J = 6.0 Hz, NH-9), 7.48 (s, H-13 and H-17), 7.37 (d, J = 2.0 Hz, H-2), 7.11 (dd, J = 8.5 Hz, 2.1 Hz, H-6), 6.97 (d, J = 8.5 Hz, H-5), 3.96 (t, J = 5.9 Hz, (H-18)2), 3.78 (s, OMe), 3.70 (s, (H-7)2), 3.35 (m, (H-10)2), 3.34 (m, (H-20)2), 2.83 (s, (NMe2), 2.72 (t, J = 7.0 Hz, H-11), 2.18 (m, (H-19)2). 13C-NMR (100 MHz, DMSO-d6) δ 163.3 (C-9), 153.0 (C-4), 151.8 (C-8), 150.2 (C-15), 139.4 (C-12), 133.1 (C-13 and C-17), 133.0 (C-2), 129.2 (C-6), 117.2 (C-14 and C-16), 113.8 (C-5), 112.6 (C-3), 110.1 (C-1), 70.2 (C-18), 56.2 (OMe), 42.4 (NMe2), 39.6 (C-10), 39.6 (C-20), 33.4 (C-11), 27.8 (C-7), 24.8 (C-19). Mass spectrum (ESI+) m/z: isotopic cluster 648:650:652:654 (in ratio 1:3:3:1).
16-Debromoaplysamine 4 (7): [49] Light brown solid (1.6 mg; 0.004% of wet weight). 1H-NMR (400 MHz, DMSO-d6) δ 11.98 (s, N-OH), 8.16 (t, J = 5.9 Hz, NH-9), 7.77 (s, NH), 7.47 (s, H-13), 7.45 (s, H-1 and H-5), 7.19 (dd, J = 8.4 Hz, 2.1 Hz, H-17), 7.00 (d, J = 8.4 Hz, H-16), 3.99 (t, J = 6.1 Hz, (H-18)2), 3.75 (s, (H-7)2), 3.74 (s, (OMe), 3.34 (m, (H-20)2), 3.00 (t, J = 7.8 Hz, (H-10)2), 2.77 (t, J = 7.7 Hz, (H-11)2), 1.92 (m, (H-19)2). 13C-NMR (100 MHz, DMSO-d6) δ 163.3 (C-9), 153.6 (C-15), 151.8 (C-3), 151.1 (C-8), 136.3 (C-6), 133.0 (C-13), 132.8 (C-1, C-5), 131.2 (C-12), 129.2 (C-17), 117.0 (C-2, C-4), 113.7 (C-16), 111.3 (C-14), 66.7 (C-18), 60.2 (OMe), 39.8 (C-10), 36.1 (C-20), 31.7 (C-11), 28.7 (C-19), 27.9 (C-7). Mass spectrum (ESI+) m/z: isotopic cluster 620:622:624:626 (in ratio 1:3:3:1).
(−)-Purealin (8): [50] Light brown solid (1.9 mg; 0.005% of wet weight). [ α ] D 20 −82° (c 0.1, MeOH), Lit. [50] −85°. 1H-NMR (400 MHz, DMSO-d6) δ 12.03 (s, N-OH), 11.85 (s, NH-22), 8.57 (bs, NH-9), 8.15 (bs, NH-19), 7.44 (s, H-15 and H-15′), 7.35 (bs, NH2-24), 6.57 (d, J = 10.6 Hz, H-5), 6.56 (s, H-23), 6.38 (bs, C1-OH), 3.90 (d, J = 8.1 Hz, H-1), 3.75 (s, (H-17)2), 3.63 (s, (OMe), 3.61 (d, J = 18.1 Hz, H-7a), 3.49 (m, (H-12)2), 3.38 (m, (H-10)2), 3.36 (m, (H-20)2), 3.20 (d, J = 18.3 Hz, H-7b), 2.59 (m, (H-21)2), 1.97 (m, (H-11)2). 13C-NMR (100 MHz, DMSO-d6) δ 163.3 (C-19), 158.9 (C-9), 154.5 (C-8), 151.7 (C-13), 151.0 (C-18), 147.1 (C-3), 136.3 (C-16), 132.9 (C-15 and C-15′), 131.3 (C-5), 124.4 (C-22), 120.8 (C-2), 117.1 (C-14 and C-14′), 113.1 (C-4), 109.2 (C-23), 90.2 (C-6), 73.6 (C-1), 69.8 (C-12), 59.4 (OMe), 39.4 (C-7), 37.3 (C-20), 36.2 (C-10), 29.4 (C-11), 27.9 (C-17), 24.5 (C-21). Mass spectrum (ESI+) m/z: isotopic cluster 880:882:884:886:888 (in ratio 1:4:6:4:1).
The opisthobranch Tylodina corticalis was extracted by soaking overnight in ethanol (5 × 50 mL) at −20 °C. The combined extracts (327.6 mg) were partitioned against petroleum ether (3 × 30 mL), ethyl acetate (4 × 30 mL) and 1-butanol (5 × 30 mL) to yield 40.1, 12.0 mg, and 95.6 mg of crude extract respectively. An aliquot (1 mg) of the ethyl acetate extract was dissolved in 10% acetonitrile/water/0.1% formic acid (1 mL) and analysed by low resolution-LC-MS (Gemini C18 column, 0.2 mL/min, gradient from 10% to 95% acetonitrile/water/0.1% formic acid over 35 min. For HR-LC-MS analysis 2 μL of samples (20 µg/mL) were loaded on a C18 trap column. After desalting, samples were eluted over 30 min from 5% acetonitrile/0.1% formic acid to 90% acetonitrile/0.1% formic acid at 300 nL/min.

4. Conclusions

This is the first report of two previously unknown brominated tyrosine derivatives (1 and 2) including a full structure analysis of these and six other compounds from Pseudoceratina purpurea. The antimicrobial activity of the isolated compounds was assessed against common human pathogens in preliminary assays and showed moderate activity for compound 2 against S. aureus. Seven further compounds found in the sponge or its predator, were tentatively assigned by UV and high resolution MS data.

Acknowledgments

The HR-LC-ESI-MS experiment was performed by the Australian Proteome Analysis Facility, Sydney. The authors acknowledge Xiaomin Song and for access to the Thermo Orbitrap Elite instrument.

Author Contributions

PK and MG collected the organisms. MG extracted and isolated the compounds and performed all the biological assays. Spectral data and structure elucidation were collected and analysed by MG and PK. MG drafted the manuscript and PK edited the final version and is responsible for its content.

Supplementary Information

Supplementary Information including details on the bioassays, biological material, HRMS and NMR data are available upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Harper, M.K.; Bugni, T.S.; Copp, B.R.; James, R.D.; Lindsay, B.S.; Richardson, A.D.; Schnabel, P.C.; Tasdemir, D.; vanWagoner, R.M.; Verbitski, S.M.; et al. Introduction to the chemical ecology of marine natural products. In Marine Chemical Ecology; McClintock, J.B., Baker, B.J., Eds.; CRC Press LLC: Boca Raton, FL, USA, 2001; pp. 3–69. [Google Scholar]
  2. Bergquist, P.R.; Wells, R.J. Chemotaxonomy of the Porifera: The development and current status of the field. In Marine Natural Products; Scheuer, P.J., Ed.; Academic: New York, NY, USA, 1983. [Google Scholar]
  3. Bergquist, P.R.; Karuso, P.; Cambie, R.C.; Smith, D.J. Sterol composition and classification of the Porifera. 3. Biochem. Syst. Ecol. 1991, 19, 17–24. [Google Scholar]
  4. Arabshahi, L.; Schmitz, F.J. Brominated tyrosine metabolites from an unidentified sponge. J. Org. Chem. 1987, 52, 3584–3586. [Google Scholar]
  5. Teeyapant, R.; Kreis, P.; Wray, V.; Witte, L.; Proksch, P. Brominated secondary compounds from the marine sponge Verongia aerophoba and the sponge feeding gastropod Tylodina perversa. Z. Naturforsch. C: Biosci. 1993, 48, 640–644. [Google Scholar]
  6. Shaala, L.A.; Bamane, F.H.; Badr, J.M.; Youssef, D.T.A. Brominated arginine-derived alkaloids from the red sea sponge Suberea mollis. J. Nat. Prod. 2011, 74, 1517–1520. [Google Scholar] [CrossRef] [PubMed]
  7. Salim, A.A.; Khalil, Z.G.; Capon, R.J. Structural and stereochemical investigations into bromotyrosine-derived metabolites from southern Australian marine sponges, Pseudoceratina spp. Tetrahedron 2012, 68, 9802–9807. [Google Scholar] [CrossRef]
  8. Jang, J.-H.; van Soest, R.W.M.; Fusetani, N.; Matsunaga, S. Pseudoceratins A and B, antifungal bicyclic bromotyrosine-derived metabolites from the marine sponge Pseudoceratina purpurea. J. Org. Chem. 2007, 72, 1211–1217. [Google Scholar] [CrossRef] [PubMed]
  9. Kon, Y.; Kubota, T.; Shibazaki, A.; Gonoi, T.; Kobayashi, J.I.; Ceratinadins, A.-C. New bromotyrosine alkaloids from an Okinawan marine sponge Pseudoceratina sp. Bioorg. Med. Chem. Lett. 2010, 20, 4569–4572. [Google Scholar] [CrossRef] [PubMed]
  10. Jurek, J.; Yoshida, W.Y.; Scheuer, P.J.; Kelly-Borges, M. Three new bromotyrosine-derived metabolites of the sponge Psammaplysilla purpurea. J. Nat. Prod. 1993, 56, 1609–1612. [Google Scholar] [CrossRef]
  11. Kobayashi, J.I.; Honma, K.; Sasaki, T.; Tsuda, M.; Purealidins, J.-R. New bromotyrosine alkaloids from the Okinawan marine sponge Psammaplysilla purea. Chem. Pharm. Bull. 1995, 43, 403–407. [Google Scholar] [CrossRef]
  12. Tsukamoto, S.; Kato, H.; Hirota, H.; Fusetani, N. Ceratinamides A and B: New antifouling dibromotyrosine derivatives from the marine sponge Pseudoceratina purpurea. Tetrahedron 1996, 52, 8181–8186. [Google Scholar] [CrossRef]
  13. Compagnone, R.S.; Avila, R.; Suarez, A.I.; Abrams, O.V.; Rangel, H.R.; Arvelo, F.; Pina, I.C.; Merentes, E. 11-Deoxyfistularin-3, a new cytotoxic metabolite from the Caribbean sponge Aplysina fistularis insularis. J. Nat. Prod. 1999, 62, 1443–1444. [Google Scholar] [CrossRef] [PubMed]
  14. Tabudravu, J.N.; Jaspars, M. Purealidin S and purpuramine J, bromotyrosine alkaloids from the Fijian marine sponge Druinella sp. J. Nat. Prod. 2002, 65, 1798–1801. [Google Scholar] [CrossRef] [PubMed]
  15. Kalaitzis, J.A.; De, A.L.P.; Hooper, J.N.A.; Quinn, R.J. Ianthesine E, a new bromotyrosine-derived metabolite from the Great Barrier Reef sponge Pseudoceratina sp. Nat. Prod. Res. 2008, 22, 1257–1263. [Google Scholar] [CrossRef] [PubMed]
  16. Teruya, T.; Iwasaki, A.; Suenaga, K. 20-N-methylpurpuramine E: New bromotyrosine-derived metabolite from Okinawan marine sponge Pseudoceratina purpurea. Bull. Chem. Soc. Jpn. 2008, 81, 1026–1027. [Google Scholar] [CrossRef]
  17. Proksch, P.; Putz, A.; Ortlepp, S.; Kjer, J.; Bayer, M. Bioactive natural products from marine sponges and fungal endophytes. Phytochem. Rev. 2010, 9, 475–489. [Google Scholar] [CrossRef]
  18. Su, J.-H.; Chen, Y.-C.; El-Shazly, M.; Du, Y.-C.; Su, C.-W.; Tsao, C.-W.; Liu, L.-L.; Chou, Y.; Chang, W.-B.; Su, Y.-D.; et al. Towards the small and the beautiful: A small dibromotyrosine derivative from Pseudoceratina sp. sponge exhibits potent apoptotic effect through targeting IKK/NFκB signaling pathway. Mar. Drugs 2013, 11, 3168–3185. [Google Scholar] [CrossRef] [PubMed]
  19. Shaala, L.A.; Youssef, D.T.A.; Sulaiman, M.; Behery, F.A.; Foudah, A.I.; El Sayed, K.A. Subereamolline A as a potent breast cancer migration, invasion and proliferation inhibitor and bioactive dibrominated alkaloids from the Red Sea sponge Pseudoceratina arabica. Mar. Drugs 2012, 10, 2492–2508. [Google Scholar] [CrossRef] [PubMed]
  20. Niemann, H.; Lin, W.; Mueller, W.E.G.; Kobbutat, M.; Lai, D.; Proksch, P. Trimeric hemibastadin congener from the marine sponge Ianthella basta. J. Nat. Prod. 2013, 76, 121–125. [Google Scholar] [CrossRef] [PubMed]
  21. Tran, T.D.; Pham, N.B.; Fechner, G.; Hooper, J.N.A.; Quinn, R.J. Bromotyrosine alkaloids from the Australian marine sponge Pseudoceratina verrucosa. J. Nat. Prod. 2013, 76, 516–523. [Google Scholar] [CrossRef] [PubMed]
  22. Xu, M.; Andrews, K.T.; Birrell, G.W.; Tran, T.L.; Camp, D.; Davis, R.A.; Quinn, R.J. Psammaplysin H, a new antimalarial bromotyrosine alkaloid from a marine sponge of the genus Pseudoceratina. Bioorg. Med. Chem. Lett. 2011, 21, 846–848. [Google Scholar] [CrossRef] [PubMed]
  23. Galeano, E.; Thomas, O.P.; Robledo, S.; Munoz, D.; Martinez, A. Antiparasitic bromotyrosine derivatives from the marine sponge Verongula rigida. Mar. Drugs 2011, 9, 1902–1913. [Google Scholar] [CrossRef] [PubMed]
  24. Mani, L.; Jullian, V.; Mourkazel, B.; Valentin, A.; Dubois, J.; Cresteil, T.; Folcher, E.; Hooper, J.N.A.; Erpenbeck, D.; Aalbersberg, W.; et al. New antiplasmodial bromotyrosine derivatives from Suberea ianthelliformis Lendenfeld, 1888. Chem. Biodivers. 2012, 9, 1436–1451. [Google Scholar] [CrossRef] [PubMed]
  25. Karuso, P. Chemical ecology of the nudibranchs. Bioorg. Mar. Chem. 1987, 1, 31–60. [Google Scholar]
  26. Hao, E.; Fromont, J.; Jardine, D.; Karuso, P. Natural products from sponges of the genus Agelas—on the trail of a [2 + 2]-photoaddition enzyme. Molecules 2001, 6, 130–141. [Google Scholar] [CrossRef]
  27. Tsukamoto, S.; Kato, H.; Hirota, H.; Fusetani, N. Pseudoceratidine: A new antifouling spermidine derivative from the marine sponge Pseudoceratina purpurea. Tetrahedron Lett. 1996, 37, 1439–1440. [Google Scholar] [CrossRef]
  28. Tsukamoto, S.; Kato, H.; Hirota, H.; Fusetani, N. Pseudoceramine: An unprecedented antifouling cyanoformamide from the marine sponge Pseudoceratina purpurea. J. Org. Chem. 1996, 61, 2936–2937. [Google Scholar] [CrossRef] [PubMed]
  29. Fusetani, N.; Masuda, Y.; Nakao, Y.; Matsunaga, S.; van Soest, R.W.M. Three new bromotyrosine derivatives lethal to crab from the marine sponge, Pseudoceratina purpurea. Tetrahedron 2001, 57, 7507–7511. [Google Scholar] [CrossRef]
  30. Takada, N.; Watanabe, R.; Suenaga, K.; Yamada, K.; Ueda, K.; Kita, M.; Uemura, D. Zamamistatin, a significant antibacterial bromotyrosine derivative, from the Okinawan sponge Pseudoceratina purpurea. Tetrahedron Lett. 2001, 42, 5265–5267. [Google Scholar] [CrossRef]
  31. Peng, X.; Deng, S.; Xiao, D.; Wu, H. Chemical constituents of the marine sponge Pseudoceratina purpurea from South China Sea (I). Guangzhou Huaxue 2003, 28, 1–4. [Google Scholar]
  32. Peng, X.; Deng, S.; Xiao, D.; Ma, W.; Wu, H. Studies on the active constituents of the marine sponge Pseudoceratina purpurea from the South China Sea. Zhongguo Haiyang Yaowu 2004, 23, 11–13. [Google Scholar]
  33. Kijjoa, A.; Bessa, J.; Wattanadilok, R.; Sawangwong, P.; Nascimento, M.S.J.; Pedro, M.; Silva, A.M.S.; Eaton, G.; van Soest, R.; Herz, W. Dibromotyrosine derivatives, a maleimide, aplysamine-2 and other constituents of the marine sponge Pseudoceratina purpurea. Z. Naturforsch. B Chem. Sci. 2005, 60, 904–908. [Google Scholar]
  34. Hertiani, T.; Edrada, R.; van, S.R.W.M.; Mueller, W.E.G.; Sudarsono Proksch, P. Chemical investigation on Pseudoceratina purpurea collected from Banyuwangi Indonesia. Indonesian J. Pharm. 2009, 20, 17–26. [Google Scholar]
  35. McCulloch, M.W.B.; Coombs, G.S.; Banerjee, N.; Bugni, T.S.; Cannon, K.M.; Harper, M.K.; Veltri, C.A.; Virshup, D.M.; Ireland, C.M. Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. Biorg. Med. Chem. 2009, 17, 2189–2198. [Google Scholar] [CrossRef]
  36. Faulkner, D.; Ghiselin, M. Chemical defense and evolutionary ecology of dorid nudibranchs and some other opisthobranch gastropods. Mar. Ecol. 1983, 13, 295–301. [Google Scholar] [CrossRef]
  37. Ebel, R.; Marin, A.; Proksch, P. Organ-specific distribution of dietary alkaloids in the marine opisthobranch Tylodina perversa. Biochem. Syst. Ecol. 1999, 27, 769–777. [Google Scholar] [CrossRef]
  38. Thoms, C.; Ebel, R.; Hentschel, U.; Proksch, P. Sequestration of dietary alkaloids by the spongivorous marine mollusk Tylodina perversa. Z. Naturforsch. C: Biosci. 2003, 58, 426–432. [Google Scholar]
  39. Thoms, C.; Ebel, R.; Proksch, P. Sequestration and possible role of dietary alkaloids in the sponge-feeding mollusk Tylodina perversa. Prog. Mol. Subcell. Biol. 2006, 43, 261–275. [Google Scholar] [PubMed]
  40. Ciminiello, P.; Fattorusso, E.; Forino, M.; Magno, S.; Pansini, M. Chemistry of verongida sponges. VIII. Bromo compounds from the Mediterranean sponges Aplysina aerophoba and Aplysina cavernicola. Tetrahedron 1997, 53, 6565–6572. [Google Scholar] [CrossRef]
  41. Encarnacion, R.D.; Sandoval, E.; Malmstrom, J.; Christophersen, C. Calafianin, a bromotyrosine derivative from the marine sponge Aplysina gerardogreeni. J. Nat. Prod. 2000, 63, 874–875. [Google Scholar] [CrossRef] [PubMed]
  42. Fendert, T.; Wray, V.; van Soest, R.W.M.; Proksch, P. Bromoisoxazoline alkaloids from the Caribbean sponge Aplysina insularis. Z. Naturforsch. C: Biosci. 1999, 54, 246–252. [Google Scholar]
  43. Venkateswarlu, Y.; Rao, M.R.; Venkatesham, U. A new dibromotyrosine-derived metabolite from the sponge Psammaplysilla purpurea. J. Nat. Prod. 1998, 61, 1388–1389. [Google Scholar] [CrossRef] [PubMed]
  44. Cimino, G.; de Rosa, S.; de Stefano, S.; Spinella, A.; Sodano, G. The zoochrome of the sponge Verongia aerophoba (“Uranidine”). Tetrahedron Lett. 1984, 25, 2925–2928. [Google Scholar] [CrossRef]
  45. Benharref, A.; Pais, M.; Debitus, C. Bromotyrosine alkaloids from the sponge Pseudoceratina verrucosa. J. Nat. Prod. 1996, 59, 177–180. [Google Scholar] [CrossRef]
  46. Cimino, G.; Rosa, S.D.; Stefano, S.D.; Self, R.; Sodano, G. The bromo-compounds of the true sponge Verongia aerophoba. Tetrahedron Lett. 1983, 24, 3029–3032. [Google Scholar] [CrossRef]
  47. Morris, S.A.; Andersen, R.J. Nitrogenous metabolites from the deep water sponge Hexadella sp. Can. J. Chem. 1989, 67, 677–681. [Google Scholar] [CrossRef]
  48. Xynas, R.; Capon, R.J. Two new bromotyrosine-derived metabolites from an Australian marine sponge, Aplysina sp. Aust. J. Chem. 1989, 42, 1427–1433. [Google Scholar] [CrossRef]
  49. Pakrashi, S.C.; Achari, B.; Dutta, P.K.; Chakrabarti, A.K.; Giri, C.; Saha, S.; Basa, S.C. Marine products from bay of Bengal: Constituents of the sponge. Tetrahedron 1994, 50, 12009–12014. [Google Scholar] [CrossRef]
  50. Nakamura, H.; Wu, H.; Kobayashi, J.; Nakamura, Y.; Ohizumi, Y.; Hirata, Y. Purealin, a novel enzyme activator from the Okinawan marine sponge Psammaplysilla purea. Tetrahedron Lett. 1985, 26, 4517–4520. [Google Scholar] [CrossRef]
  51. Peng, J.; Li, J.; Hamann, M.T. The marine bromotyrosine derivatives. In The Alkaloids: Chemistry and Biology; Cordell, G.A., Ed.; Academic Press: San Diego, CA, USA, 2005; Volume 61, pp. 59–262. [Google Scholar]
  52. Mukai, H.; Kubota, T.; Aoyama, K.; Mikami, Y.; Fromont, J.; Kobayashi, J. Tyrokeradines A and B, new bromotyrosine alkaloids with an imidazolyl-quinolinone moiety from a Verongid sponge. Bioorg. Med. Chem. Lett. 2009, 19, 1337–1339. [Google Scholar] [CrossRef] [PubMed]
  53. Gershenzon, J.; Dudareva, N. The function of terpene natural products in the natural world. Nat. Chem. Biol. 2007, 3, 408–414. [Google Scholar] [CrossRef] [PubMed]
  54. Willan, R.C. A review of the diets in the Notaspidea (Mollusca: Opisthobranchia). J. Malacol. Soc. Aust. 1984, 6, 125–142. [Google Scholar]
  55. Thoms, C.; Schupp, P.J. Activated chemical defense in marine sponges—A case study on Aplysinella rhax. J. Chem. Ecol. 2008, 34, 1242–1252. [Google Scholar] [CrossRef] [PubMed]
  56. Becerro, M.A.; Turon, X.; Uriz, M.J.; Templado, J. Can a sponge feeder be a herbivore? Tylodina perversa (Gastropoda) feeding on Aplysina aerophoba (Demospongiae). Biol. J. Linn. Soc. 2003, 78, 429–438. [Google Scholar]
  57. Cimino, G.; Sodano, G. Biosynthesis of secondary metabolites in marine mollusks. Top. Curr. Chem. 1993, 167, 77–115. [Google Scholar]
  58. Hooper, J.N.A. “Sponguide”. Guide to Sponge Collection and Identification; Queensland Museum: Brisbane, Australia, 2000. [Google Scholar]

Share and Cite

MDPI and ACS Style

Gotsbacher, M.P.; Karuso, P. New Antimicrobial Bromotyrosine Analogues from the Sponge Pseudoceratina purpurea and Its Predator Tylodina corticalis. Mar. Drugs 2015, 13, 1389-1409. https://doi.org/10.3390/md13031389

AMA Style

Gotsbacher MP, Karuso P. New Antimicrobial Bromotyrosine Analogues from the Sponge Pseudoceratina purpurea and Its Predator Tylodina corticalis. Marine Drugs. 2015; 13(3):1389-1409. https://doi.org/10.3390/md13031389

Chicago/Turabian Style

Gotsbacher, Michael P., and Peter Karuso. 2015. "New Antimicrobial Bromotyrosine Analogues from the Sponge Pseudoceratina purpurea and Its Predator Tylodina corticalis" Marine Drugs 13, no. 3: 1389-1409. https://doi.org/10.3390/md13031389

APA Style

Gotsbacher, M. P., & Karuso, P. (2015). New Antimicrobial Bromotyrosine Analogues from the Sponge Pseudoceratina purpurea and Its Predator Tylodina corticalis. Marine Drugs, 13(3), 1389-1409. https://doi.org/10.3390/md13031389

Article Metrics

Back to TopTop